In 2026, if you need a prostatectomy, a hysterectomy, or a complex colorectal resection at a major Australian hospital, there's a good chance a robot will be doing most of the cutting. Robotic surgery has crossed the threshold from experimental to standard of care — and the latest generation of AI-guided systems is pushing the boundaries of what's surgically possible.

The da Vinci 5: A Decade of Refinement

Intuitive Surgical's da Vinci system has been the dominant surgical robot for twenty years. The fifth generation, launched in 2024, represents the most significant upgrade in the platform's history. The addition of force feedback — which allows surgeons to feel tissue resistance through the robotic instruments — addresses the most significant limitation of previous generations. The new AI-assisted features include automatic tremor filtration, real-time tissue identification using fluorescence imaging, and procedure-specific guidance that alerts surgeons to anatomical landmarks.

More than 10,000 da Vinci systems are now installed worldwide. In 2025, they performed 2.2 million procedures — a 15% increase over the previous year. The evidence base for robotic surgery outcomes is now substantial: across prostatectomy, hysterectomy, and colorectal surgery, robotic approaches consistently show reduced blood loss, shorter hospital stays, and faster recovery compared to open surgery.

The New Challengers

Medtronic's Hugo RAS system has broken Intuitive's near-monopoly. Hugo's modular architecture — separate robotic arms that can be positioned independently — gives it flexibility advantages in complex procedures. It's now approved in 50 countries and is gaining market share in Europe and Asia-Pacific.

CMR Surgical's Versius system takes a different approach: a smaller, more portable platform designed for hospitals that can't justify the $2 million cost of a da Vinci installation. Versius has been particularly successful in the UK's NHS, where its lower cost and smaller footprint have enabled robotic surgery in district general hospitals that previously couldn't access the technology.

AI-Guided Surgery: The Next Frontier

The most exciting development in surgical robotics isn't the hardware — it's the AI. Systems like Activ Surgical's ActivSight and Moon Surgical's Maestro are adding real-time AI guidance to existing surgical platforms, providing surgeons with information they couldn't previously access during a procedure: tissue perfusion maps that identify blood supply, depth perception enhancement, and AI-generated alerts when instruments approach critical structures.

The logical endpoint of this trajectory — fully autonomous robotic surgery — remains controversial and distant. But semi-autonomous systems that handle specific subtasks (suturing, tissue dissection, haemostasis) under surgeon supervision are already in clinical trials. The Smart Tissue Autonomous Robot (STAR) at Johns Hopkins has performed autonomous intestinal anastomosis with outcomes superior to human surgeons in animal studies.

The Access Problem

The most significant challenge in surgical robotics isn't technical — it's economic. A da Vinci system costs $1.5–2.5 million to purchase and $150,000–$200,000 per year to maintain. This concentrates robotic surgery in wealthy, urban hospitals. Addressing this disparity — through lower-cost systems, shared access models, and telesurgery — is the defining challenge for the field in the next decade.

Telesurgery: Operating Across Distances

One of the most transformative potential applications of surgical robotics is telesurgery — performing operations remotely, with a surgeon controlling a robotic system from a different location. In 2019, a Chinese surgeon performed the world's first 5G-enabled remote surgery, operating on a patient 50km away. In 2023, a Canadian surgeon performed a laparoscopic procedure on a patient in a different city. The technology works — the challenge is latency, reliability, and regulatory approval.

For rural and remote communities in Australia — where access to specialist surgical care requires travelling hundreds of kilometres — telesurgery could be transformative. The CSIRO and several Australian universities are actively researching telesurgery systems designed for the Australian context, with trials planned at regional hospitals in Queensland and Western Australia.

Training the Next Generation of Surgeons

Surgical robots are also transforming surgical education. The da Vinci system's simulation mode allows trainees to practice procedures on virtual patients before operating on real ones. AI-powered performance analytics track every movement, identifying areas for improvement and comparing trainee performance to expert benchmarks. Studies show that surgeons trained on robotic simulators reach competency faster and with fewer errors than those trained through traditional apprenticeship models alone.

Sources & Further Reading